NCT04359277, 0 NCT04359277
anticoagulant vs. anticoagulant
COVID 19 all comers
CORIMMUNO-COAG, 0 NCT04344756
anticoagulant vs. standard of care
COVID 19 all comers
ChiCTR2000030701, 0 ChiCTR2000030701
enoxaparin vs. standard of care
COVID 19 all comers
Union Hospital, Tongji Medical College of Huazhong University, 0 ChiCTR2000030700
enoxaparin vs. standard of care
COVID 19 all comers
REMA-CAP COVID, 0
anticoagulant vs. control
COVID 19 hospitalized
Paranjpe, 2020
anticoagulant vs. control
COVID 19 hospitalized
Bousquet, 2020
anticoagulant, curative dose vs. anticoagulant, curative dose
COVID 19 hospitalized
COALIZAO ACTION, 2021 NCT04394377
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID 19 hospitalized
Bousquet, 2020
anticoagulant, curative dose vs. control
COVID 19 hospitalized
Bousquet, 2020
anticoagulant, prophylactic dose vs. anticoagulant, curative dose
COVID 19 hospitalized
Bousquet, 2020
anticoagulant, prophylactic dose vs. control
COVID 19 hospitalized
X-COVID-19, 2021 NCT04366960
anticoagulant vs. control
COVID-19 mild to moderate
ATTACC, ACTIV-4a, and REMAP-CAP (noncritically ill patients), 2021 NCT02735707
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID-19 mild to moderate
NCT04444700, 0 NCT04444700
enoxaparin vs. standard of care
COVID-19 mild to moderate
RAPID (Sholzberg), 2021 NCT04362085
heparin at therapeutic dose vs. standard of care
COVID-19 mild to moderate
REMAP-CAP, ACTIV-4a, ATTACC (critically ill patients), 2021 NCT02735707
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID-19 severe or critically
COVID-PACT, 2022
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID-19 severe or critically
Tang, 2020
anticoagulant, prophylactic dose vs. control
COVID-19 severe or critically
INSPIRATION, 2021 NCT04486508
anticoagulation, intermediate prophylactic dose vs. anticoagulant, prophylactic dose
COVID-19 severe or critically
NCT04445935, 0 NCT04445935
Bivalirudin vs. standard of care
COVID-19 severe or critically
ATTACC (Houston), 0 NCT04372589
heparin at therapeutic dose vs. control
COVID-19 severe or critically
REMAP-CAP Anticoagulation, 0 NCT02735707
heparin at therapeutic dose vs. control
COVID-19 severe or critically
ACTIV-4a (heparin), 0 NCT04505774
heparin at therapeutic dose vs. control
COVID-19 severe or critically
NCT04445623, 0 NCT04445623
P2Y12 inhibitors vs. placebo
COVID-19 severe or critically